Modulation of matrix metalloproteinase activities in periodontitis as a treatment strategy

Periodontol 2000. 2000 Oct;24:226-38. doi: 10.1034/j.1600-0757.2000.2240111.x.
No abstract available

Publication types

  • Review

MeSH terms

  • Alveolar Bone Loss / drug therapy
  • Alveolar Bone Loss / enzymology
  • Animals
  • Chelating Agents / therapeutic use
  • Clinical Trials as Topic
  • Enzyme Induction
  • Extracellular Matrix / metabolism
  • Humans
  • Hydroxamic Acids / therapeutic use
  • Matrix Metalloproteinase Inhibitors*
  • Matrix Metalloproteinases / metabolism*
  • Periodontitis / drug therapy*
  • Periodontitis / enzymology*
  • Protease Inhibitors / therapeutic use*
  • Tetracyclines / therapeutic use
  • Up-Regulation

Substances

  • Chelating Agents
  • Hydroxamic Acids
  • Matrix Metalloproteinase Inhibitors
  • Protease Inhibitors
  • Tetracyclines
  • Matrix Metalloproteinases